ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease.

Jorge Garcia Condado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.